Phase 2 Trial of LDE225 and Lenalidomide Maintenance Post Autologous Stem Cell Transplant for Multiple Myeloma
Latest Information Update: 16 Jun 2020
At a glance
- Drugs Lenalidomide (Primary) ; Sonidegib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 27 May 2020 Planned End Date changed from 30 Jan 2020 to 30 Jan 2021.
- 10 Dec 2019 Results assessing safety and efficacy of LDE225 and lenalidomide maintenance post autologous stem cell transplant in multiple myeloma patients, presented at the 61st Annual Meeting and Exposition of the American Society of Hematology.
- 06 May 2019 Planned End Date changed from 30 Jan 2019 to 30 Jan 2020.